Minute Insight: Inivata's RaDaR Assay Study Yields Encouraging Results
RaDaR, a test for head and neck squamous cell carcinoma, demonstrated high efficacy in a new study.
You may also be interested in...
Inivata will remain a separate liquid biopsy division alongside NeoGenomics’ growing clinical, pharma and informatics divisions.
The Memorial Sloan Kettering spin-out has received CE-IVD and UKCA marks for its artificial intelligence software designed to identify HER2 expression in biopsies.
Nothing except a name, but Creo Medical says its Speedboat Inject device can turn some surgeries from prolonged hospital stays into one-day visits.